摘要
目的:观察冠心病患者可溶性肿瘤坏死因子受体(STNFR)的改变与临床意义。方法:STNFR采用酶联免疫双抗体夹心法测定。结果:血清STNFR(ng/ml)在急性心肌梗死患者(3.55±2.01,n=29)和冠心病心肌缺血患者(1.99±0.62,n=23)中均较正常对照有所升高(0.93±0.29,n=61,P均<0.01),急性心肌梗死并发心力衰竭死亡时STNFR升高达正常值7.7倍(7.23±1.60,n=5),心肌缺血患者中心功能II、IV级(2.53±0.46,n=7)较I、I级者(1.73±0.50,n=16)升高明显(P<0.01)。结论:冠心病患者中STNFR水平与病情严重程度密切相关,并能预测急性心肌梗死患者预后。
Objective:To identify whether there are changes of serum soluble tumor necrosis factor receptor (STNFR) in patients with coronary heart disease (CHD) and analyse its clinical significance. Methods:Fifty two cases with CHD were studied.Serum STNFR was examined by enzyme linked immunosorkent assay (ELISA). Results:STNFR both in patients with acute myocardial infarction (AMI)(3 55±2 01 ng/ml, n =29) and with myocardial ischemia (1 99±0 62 ng/ml, n =23)were higher than that in control(0 93±0 29 ng/ml, n =61, p <0 01).In AMI patients died of heart failure,the STNFR(7 23±1 60 ng/ml, n =5) was significantly increased to 7 7 fold of control, while in myocardial ischemic patients,the STNFR elevated with the worsening of heart function.STNFR in patients with heart function (NYHA) of III and IV classes(2 53±0 46 ng/ml, n =7) was higher than in those of I and II classes (1 73±0 50 ng/ml, n =16, p <0 01). Conclusion:STNFR level is closely correlated to the severity of patients with CHD, and it might predict the prognosis of acute myocardial infarction.
出处
《中国循环杂志》
CSCD
北大核心
1997年第3期195-197,共3页
Chinese Circulation Journal
关键词
冠心病
肿瘤坏死因子
受体
酶标法
Coronary heart disease
Soluble tumor necrosis factor receptor
Enzyme immunoassay